anti-tirzepatide antibodies Every successful therapeutic antibody starts with one crucial question: "Is this antibody binding to a unique epitope—or competing with another?" For years, researchers have relied on workflows that are time-consuming, label-dependent, and anti-tirzepatide antibodies Diagram of IgG

Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects

As a board-certified, fellowship-trained surgeon, I have witnessed firsthand the transformative power of this medication when integrated into a comprehensive, medically supervised weight loss program

Zepbound is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

And this is a low-grade inflammation

Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls